Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors
- PMID:17986216
- DOI: 10.1111/j.1471-4159.2007.05063.x
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors
Abstract
Agonist-induced internalization of G protein-coupled receptors (GPCRs) is an important mechanism for regulating signaling transduction of functional receptors at the plasma membrane. We demonstrate here that both caveolae/lipid-rafts- and clathrin-coated-pits-mediated pathways were involved in agonist-induced endocytosis of the cannabinoid type 1 receptor (CB1R) in stably transfected human embryonic kidney (HEK) 293 cells and that the internalized receptors were predominantly sorted into recycling pathway for reactivation. The treatment of CB1 receptors with the low endocytotic agonist Delta9-THC induced a faster receptor desensitization and slower resensitization than the high endocytotic agonist WIN 55,212-2. In addition, the blockade of receptor endocytosis or recycling pathway markedly enhanced agonist-induced CB1 receptor desensitization. Furthermore, co-expression of phospholipase D2, an enhancer of receptor endocytosis, reduced CB1 receptor desensitization, whereas co-expression of a phospholipase D2 negative mutant significantly increased the desensitization after WIN 55,212-2 treatment. These findings provide evidences for the importance of receptor endocytosis in counteracting CB1 receptor desensitization by facilitating receptor reactivation. Moreover, in primary cultured neurons, the low endocytotic agonist Delta9-THC or anandamide exhibited a greater desensitization of endogenous CB1 receptors than the high endocytotic agonist WIN 55,212-2, CP 55940 or 2-arachidonoyl glycerol, indicating that cannabinoids with high endocytotic efficacy might cause reduced development of cannabinoid tolerance to some kind cannabinoid-mediated effects.
Similar articles
- Internalization and recycling of the CB1 cannabinoid receptor.Hsieh C, Brown S, Derleth C, Mackie K.Hsieh C, et al.J Neurochem. 1999 Aug;73(2):493-501. doi: 10.1046/j.1471-4159.1999.0730493.x.J Neurochem. 1999.PMID:10428044
- Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.Gyombolai P, Boros E, Hunyady L, Turu G.Gyombolai P, et al.Mol Cell Endocrinol. 2013 Jun 15;372(1-2):116-27. doi: 10.1016/j.mce.2013.03.013. Epub 2013 Mar 27.Mol Cell Endocrinol. 2013.PMID:23541635
- [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].Iatsenko NM, Tsintsadze TSh, Lozova NO.Iatsenko NM, et al.Fiziol Zh (1994). 2007;53(3):31-7.Fiziol Zh (1994). 2007.PMID:17725041Ukrainian.
- Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.Ashton JC, Wright JL, McPartland JM, Tyndall JD.Ashton JC, et al.Curr Med Chem. 2008;15(14):1428-43. doi: 10.2174/092986708784567716.Curr Med Chem. 2008.PMID:18537620Review.
- [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].Tomiyama K, Funada M.Tomiyama K, et al.Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Jun;47(3):135-43.Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012.PMID:22894054Review.Japanese.
Cited by
- Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice.Nealon CM, Henderson-Redmond AN, Hale DE, Morgan DJ.Nealon CM, et al.Neuropharmacology. 2019 Apr;148:151-159. doi: 10.1016/j.neuropharm.2018.12.026. Epub 2019 Jan 8.Neuropharmacology. 2019.PMID:30629988Free PMC article.
- CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses.Younts TJ, Chevaleyre V, Castillo PE.Younts TJ, et al.J Neurosci. 2013 Aug 21;33(34):13743-57. doi: 10.1523/JNEUROSCI.0817-13.2013.J Neurosci. 2013.PMID:23966696Free PMC article.
- Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?Smith TH, Sim-Selley LJ, Selley DE.Smith TH, et al.Br J Pharmacol. 2010 Jun;160(3):454-66. doi: 10.1111/j.1476-5381.2010.00777.x.Br J Pharmacol. 2010.PMID:20590557Free PMC article.Review.
- The endocannabinoid system in anxiety, fear memory and habituation.Ruehle S, Rey AA, Remmers F, Lutz B.Ruehle S, et al.J Psychopharmacol. 2012 Jan;26(1):23-39. doi: 10.1177/0269881111408958. Epub 2011 Jul 18.J Psychopharmacol. 2012.PMID:21768162Free PMC article.Review.
- Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.Yeatman HR, Lane JR, Choy KH, Lambert NA, Sexton PM, Christopoulos A, Canals M.Yeatman HR, et al.J Biol Chem. 2014 May 30;289(22):15856-66. doi: 10.1074/jbc.M113.536672. Epub 2014 Apr 21.J Biol Chem. 2014.PMID:24753247Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous